Insider Profile
Lennox, Ryan Christopher
$HLS
1
Companies Filed At
1
Open-Market Buys (2yr)
$8K
Buy Value (2yr, open-market)
Sep 08, 2026
Most Recent Trade
Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days
$HLS 55
HLS Therapeutics Inc.
$8K · 1 buy
Last buy Sep 08, 2026
Date Company Role Nature Dir. Shares Price Value Score
Sep 08, 2026 $HLS
HLS Therapeutics Inc.
— Open Market Buy 2,000 $3.83 $8K 55
Jun 26, 2026 $HLS
HLS Therapeutics Inc.
— Comp. Grant Buy 35,000 $4.14 $145K 55
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.